Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.

Part of CSL Ltd., CSL Behring GmbH is a German company located in Marburg. The firm manufactures plasma protein bio therapeutics for the treatment of rare and major diseases. Michael Schröder, Lutz Guenter Bonacker and Craig Shelanskey are the current co-CEOs of the firm.

Giltech Ltd. specialized in biodegradable and controlled release technologies. The company offered research and development services for alginates, water soluble glasses, and biodegradable polymers and composites. The company was founded in 1984 and was headquartered in Ayr, UK.

Among the company's products is a beta-emitting adhesive that aids in the regulation of radioactive injection straight into tumors. It allows clinicians to help prevent problems after lung and liver biopsies and other localized treatments.

Biophilia provides regenerative medicine materials and implantable medical device solutions covering clinical surgery. They offer products for minimally invasive surgery, hernia and abdominal wall surgery, dentistry, neurosurgery, and protective products.

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. Since its establishment in 1983 the company has been dedicated to improving the lives of patients. Octapharma was founded in 1983 on the fundamental principle of improving the lives of patients. Since then we have remained focused on our collective responsibility for the trust instilled in us by physicians and patients worldwide. In 2012, the Octapharma Board identified the core strategic pillars which will lead to the achievement of the organization’s ambitious long term goals.

Founded in 2004, Rapid Pathogen Screening, Inc. (RPS®) is an emerging developer, manufacturer, and marketer of rapid point-of-care (POC) diagnostic tests. The company’s innovative and patented technology platform facilitates the development of a spectrum of cost-effective tests to rapidly identify patients with infectious diseases and inflammatory conditions. As a result of U.S. government contracts, this platform is also being used to develop tests for bio-terrorism and chemical nerve agent blood toxins. RPS tests have high sensitivity and specificity, and can be easily performed by a clinician or their staff without extensive training or additional equipment. For more information on RPS or its products, visit RPSdetectors.com.

Part of Medtronic Plc, Covidien Pte Ltd. is a Singaporean company located in Singapore that manufactures and supplies medical equipment.

Boston Scientific Ltd., part of Boston Scientific Corp., is a British company located in Hemel Hempstead. The firm distributes medical products. It was founded in 1992.\nThe company says this about itself: Boston Scientific Ltd designed, manufactured and sold transvaginal mesh (“TVM”) medical devices that were implanted into thousands of Canadian women for the treatment of Stress Urinary Incontinence (“SUI”) and Pelvic Organ Prolapse (“POP”).

Foraxon AB is developing a biodegradable wrap-around nerve conduit/prosthesis, AxonScaff that can be combined with nerve growth factor producing cells for the treatment of the peripheral nerve damage, potentially also suitable for spinal cord injuries. The biocompatible, biodegradable, conduit consisting of Polyhydroxybuturate (PHB), bridges the gap between severed nerve ends, bringing them together, and creating a protective environment for nerve growth.\nForaxon is working on an alternative, namely transplanting cells which can produce nerve-growth factors combined with a biocompatible and biodegradable nerve guide made of poly hydroxyl butyrate (PHB).

ARCH Development Corp., part of The University of Chicago, is an American company that provides job training and housing development services. Duane Gautier is currently the CEO of the firm.

Sirus Pharmaceuticals Ltd, a subsidiary of Sosei Group Corp., is a British company located in Cambridge. The firm manufactures pharmaceuticals targeting the nervous system. It was acquired by Sosei R&D Ltd., a subsidiary of Sosei Group Corp. since July 2005, from Drumz Plc on March 15, 2004.

Shandong Zhushi Pharmaceutical Group Co., Ltd., founded in December 2003, has 58 subsidiaries. It is a large comprehensive enterprise group integrating research, development, production and sales of medical devices, epidemic prevention products, health food, cosmetics and biological reagents, real estate development, logistics and distribution, and enterprise training. With a registered capital of 150 million yuan, the subsidiaries are mainly distributed in Tianjin, Shanghai, Jinan, Rizhao, Shaanxi and other places. The Group has more than 5000 registered employees, including 52 R&D technicians (doctors and masters). The Group has been successively rated as a Chinese enterprise innovation brand, a Chinese health industry innovation enterprise, a national enterprise management unit, a national consumer trusted AAA brand enterprise, a Shandong quality and integrity AAA brand enterprise, a Shandong high-tech enterprise, a Shandong consumer satisfaction unit, a Shandong intellectual property rights demonstration enterprise, a Shandong contract abiding unit, a Shandong science and technology project undertaking unit Director of the People's Daily, Mayor of Heze Quality Award. The Group Company has built Shandong Zhushi Pharmaceutical Group Health Industrial Park in Shandong Shan County Food and Drug Industrial Park, which integrates production and processing, e-commerce marketing and logistics distribution. At present, there are more than 100 series and more than 300 varieties of products. We will strive to reach 100 products for each subsidiary by 2030, achieve the strategic goal of 10 billion yuan in scale and capacity, and build a civilized and harmonious new Zhushi. The company has won three national invention patents, sixteen national utility model patents, two third prizes of Shandong Province's technological innovation achievements, three second prizes of the Municipal Science and Technology Progress Award, and two third prizes of the Municipal Science and Technology Progress Award. The company has trained a group of professional technical R&D personnel, optimized the industrial structure of the enterprise, and established the leading position of the enterprise in the industry. A number of patented technologies and applications in the products have enhanced the competitiveness of the enterprise and played a certain role in stimulating and demonstrating the structural adjustment of the foreign medical device industry and the development of related industries. Recently, some medical polymer products have been developed: medical hydrogel eye patch, vaginal packing gel, scar patch, uterine tissue suction tube set, chitosan wound liquid dressing, retaining needle, series of catheters and other products. It is equipped with 100000 level partial 100 level purification workshop and supporting inspection facilities, which can provide reliable technical support for the engineering technology research of medical polymer products in Shandong Province. With the concern and support of the Party and the government, Chairman Zhu Kunfu won two second prizes and one third prize of municipal scientific and technological achievements. He was rated as China's Excellent Entrepreneur, President of Shandong Cosmetics Association, Advanced Individual of Heze City's Ideological and Political Work, Top Talent at the municipal level, Executive Director of the Municipal Invention Association, and Vice President of the Municipal Medical Device Association. He published more than ten papers in journals and wrote more than ten kinds of books by himself. The Group has realized the modernization of production, standardization of quality and standardization of management. The Group Company has gathered talents from all directions and implemented the development strategy of big brand, big variety, big marketing and big production based on the business philosophy of "credit first, quality survival, and business ethics". Build a civilized and harmonious new Zhu family.

SynGenix Ltd. is a British private company located in Cambridge that develops and supplies neurological disease pharmaceuticals. It was founded by Hermann M. Hauser.

GATT Technologies BV develops a soluble surgical tape. It manufactures a polymer-based general adhesive tissue tape that is used as a surgical sealant for various surgical applications. The company was founded in August 2011 by Johan Bender and Andr�� de Lege and is headquartered in Nijmegen, the Netherlands.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.